Bariatric surgery in patients with type 2 diabetes: A viable option

Postgraduate Medicine

Volumn 123, Issue 1, 2011, Pages 24-33

  Colucci, Randall A ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Bariatric surgery; Enteroinsular axis; Obesity; Type 2 diabetes mellitus

Indexed keywords

GASTROINTESTINAL HORMONE; INCRETIN; ANTIDIABETIC AGENT; GLUCOSE;

ARTICLE; BARIATRIC SURGERY; BEHAVIOR THERAPY; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; LAPAROSCOPIC SURGERY; LIPOTOXICITY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREVALENCE; REMISSION; RISK BENEFIT ANALYSIS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL MORTALITY; SURGICAL TECHNIQUE; METHODOLOGY; REVIEW; RISK FACTOR; CALORIC RESTRICTION; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; DIET THERAPY; DISEASE ASSOCIATION; EXERCISE; GASTRIC BANDING; GLYCEMIC CONTROL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LOW CALORY DIET; MORTALITY; NUTRITIONAL DEFICIENCY; PATIENT SAFETY; REOPERATION; RETROSPECTIVE STUDY; SURGICAL RISK; TREATMENT INDICATION; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; PATIENT SELECTION; RISK FACTORS;

EID: 84856819561     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.01.2242     Document Type: Article

References (66)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-1200.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787.
3. Ferchk CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes- a systematic review. Diabetes Metab Res Rev. 2004;20(6):438-445.
4. Ogden CL, Carroll MD, Curtain LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
5. Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav. 2005;86(5):599-602.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.
7. Neel J. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353-362.
8. Speakman JR. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis. Int J Obes. 2008;32(11):1611-1617.
9. Grundy SM, Cleeman JL, Daniels SR, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and Management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005;112(17):e297 and 2005;112:e298]. Circulation. 2005;112(17):2735-2752.
10. Lementowski PW, Zelicof SB. Obesity and osteoarthritis. Am J Orthop (Belle Mead NJ). 2008;37(3):148-151.
11. Muzumdar H, Rao M. Pulmonary dysfunction and sleep apnea in morbid obesity. Pediatr Endocrinol Rev. 2006;3(suppl 4):579-583.
12. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523-1529.
13. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Ann Intern Med. 2000;160(7):898-904.
14. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task Force on Epidemiology and Prevention; National Heart, Lung, and Blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645.
15. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144(12):5159-5165.
16. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid induced insulin resistance in human resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and lkappaB-alpha. Diabetes. 2002;51(7):2005-2011.
17. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932.
18. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes. 1986;35(9):990-998.
19. Dixon JB, Pories WJ, O'Brien P, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28(2):472-474.
20. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-350.
21. Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91(11):4223-4231.
22. Rodriguez-Grunert L, Galvao Neto GP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4(1):55-59.
23. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14(4):275-278.
24. Giard J. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes Metab. 2008;34(6 pt 1):550-559.
25. Buchwald H, Braunwald E, Pories FW, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
26. Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg. 2009;19(5):641-644.
27. Long SD, O'Brien K, MacDonald KG, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994;17(5):372-375.
28. Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocinol Metab. 2008;93:S89-S96.
29. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med. 2004;351:2683-2693.
30. Pinkey JH, Kerrigan D. Current status of bariatric surgery in the treatment of type 2 diabetes. Obes Rev. 2004;5(1):69-78.
31. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Eng J Med. 2007;357(8):753-761.
32. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323.
33. Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83(8):897-906.
34. Cummings DE, Overduin J, Foster-Schubert KE, et al. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89(6):2608-2615.
35. de Paula AL, Macedo AL, Prudenta AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")-pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464-467.
36. Ramos AC, Galvao Neto MP, de Souza YM, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI less than 30 kg/m2 (LBMI). Obese Surg. 2009;19(3):307-312.
37. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467-485.
38. Deitel M. From bariatric to metabolic surgery in non-obese subjects: time for some caution. Arq Bras Endocrinol Metab. 2009;53(2):246-251.
39. Mason EE. Ileal transposition and enteroglucagon/BLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9(3):223-228.
40. Cohen RV, Schiavon GA, Pinheiro JS, Correa JL, Rubino F. Duodenaljejunal bypass for the treatment of type 2 diabetes with BMI 22-24 kg/m2: a report of two cases. Surg Obes Relat Dis. 2007;3(2):195-197.
41. Rubino F, Kaplan LM, Schauer PR, Cummings DE; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399-405.
42. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
43. Folli F, Pontiroli AE, Schweisinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am. 2007;91(3):393-414.
44. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in the body weight regulation and glucose metabolism. Ann Surg. 2004;240:236-242.
45. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741-749.
46. Thaler JP, Cummings DE. Hormonal mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518-2525.
47. Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299(3):341-343.
48. Ferrannini E, Mingrove G. Impact of different bariatric surgical procedures on insulin action and beta cell function in type 2 diabetes. Diabetes Care. 2009;32(3):515-520.
49. Pratt GM, McLees B, Pories WJ. The ASBS Bariatric Surgery Centers of Excellence Program: a blueprint for quality improvement. Surg Obes Relat Dis. 2006;2:497-503.
50. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol and Metab. 2010;95(11):4823-4843.
51. Allied Health Sciences Section Ad Hoc Nutrition Committee; Aills L, Blankenship J, Buffington C, Furtado M, Parrott J. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008;4(5 suppl):S73-S108.
52. Mechanick J, Kushner R, Sugerman H, et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support for the bariatric surgery patient. Surg Obes Relat Dis. 2008;4(5 suppl):S109-S184.
53. Sogg S, Mori DL. The Boston interview for gastric bypass: determining the psychological suitability of surgical candidates. Obes Surg. 2004;14(3):370-380.
54. Pratt J, Lender C, Dionne E, et al. Best practice update for pediatric/ adolescent weight loss surgery. Obesity. 2009;17(5):901-910.
55. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181.
56. Rhode BM, Tamin H, Gilfix BM, Sampalis JS, Nohr C, MacLean LD. Treatment of vitamin B12 deficiency after gastric surgery for severe obesity. Obes Surg. 1995;5(2):154-158.
57. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality on swedish obese subjects. New Engl J Med. 2007;(357):741-752.
58. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscl Thromb Vasc Biol. 2003;23(6):1042-1047.
59. Primrose JN, Davies JA, Prentice CR, Hughes R, Johnson D. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68(4):396-399.
60. Kopp CW, Kopp HP, Steiner S, et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res. 2003;11(8):950-960.
61. The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium; Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445-454.
62. Livingston EH. Bariatric surgery outcomes at designated centers of excellence vs nondesignated programs. Arch Surg. 2009;144(4):319-325.
63. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and costeffectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41): 1-190, iii-iv.
64. Tice JA, Karliner L, Walsh J, Petersen AJ. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885-893.
65. Colagiuri R, Colagiuri S, Yach D, Pramming S. The answer to diabetes prevention: science, surgery, service delivery, or social policy? Am J Public Health. 2006;96(9):1562-1569.
66. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001;120:669-681.